CareDx, Inc. Hits New 52-Week High of $24.12, Surges 61.39%

CareDx, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by hitting a new 52-week high of USD 24.12 on June 15, 2026. This achievement underscores the company's robust performance over the past year, with a remarkable increase of 61.39%, significantly outpacing the S&P 500's growth of 26.39%. The company has demonstrated impressive financial metrics, including a substantial operating profit growth of 426.01% reported on March 26. CareDx has also shown consistent positive results over the last three consecutive quarters, reflecting its operational strength. Notably, the operating cash flow reached its highest at USD 72.95 million, while the pre-tax profit for the latest quarter stood at USD 3.38 million, marking a growth of 204.24%. Additionally, the net profit for the same period was USD 3.41 million, reflecting a growth of 203.07%. With a market capitalization of USD 859 million and high institutional holdings at 100%, CareDx, Inc. continues to solidify its position in the market, showcasing its potential for sustained performance in the competitive biotechnology landscape.